Send us Feedback

Langer (GAIT)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

GAIT » Topics » DOCUMENTS INCORPORATED BY REFERENCE

These excerpts taken from the GAIT 10-K filed Mar 31, 2008.

DOCUMENTS INCORPORATED BY REFERENCE

The information required by Part III of this report is incorporated herein by reference to the Company’s proxy statement for the 2008 annual meeting of the registrant’s stockholders, which will be filed not later than 120 days after the end of the fiscal year covered by this report.

 

 

DOCUMENTS INCORPORATED BY REFERENCE



The information required by Part III of this report is incorporated herein by reference to the Company’s proxy statement for the 2008 annual meeting of the registrant’s stockholders, which will be filed not later than 120 days after the end of the fiscal year covered by this report.



 


 









This excerpt taken from the GAIT 10-K filed Apr 2, 2007.

DOCUMENTS INCORPORATED BY REFERENCE

The information required by Part III of this report is incorporated herein by reference to the Company’s proxy statement for the 2007 annual meeting of the registrant’s stockholders, which will be filed not later than 120 days after the end of the fiscal year covered by this report.

 





This excerpt taken from the GAIT 10-K filed Mar 31, 2006.

DOCUMENTS INCORPORATED BY REFERENCE

The information required by Part III of this report is incorporated herein by reference to the Company’s proxy statement for the 2006 annual meeting of the registrant’s stockholders, which will be filed not later than 120 days after the end of the fiscal year covered by this report.

 



This excerpt taken from the GAIT 10-K filed Mar 30, 2005.

DOCUMENTS INCORPORATED BY REFERENCE

        The information required by Part III of this report is incorporated herein by reference to the Company's proxy statement for the 2005 annual meeting of the registrant's stockholders or amendment hereto which will be filed not later than 120 days after the end of the fiscal year covered by this report.


Langer, Inc.

Annual Report on Form 10-K
For The Year Ended December 31, 2004

Table of Contents

 
    
   Page
    PART I    
         
ITEM 1.   BUSINESS   1
ITEM 2.   PROPERTIES   30
ITEM 3.   LEGAL PROCEEDINGS   31
ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS   31

 
 
PART II
 
 
         
ITEM 5.   MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES   32
ITEM 6.   SELECTED FINANCIAL DATA   33
ITEM 7.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   35
ITEM 7A.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK   56
ITEM 8.   FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA   57
ITEM 9.   CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE   92
ITEM 9A.   CONTROLS AND PROCEDURES   92
ITEM 9B.   OTHER INFORMATION   92

 
 
PART III
 
 
         
ITEM 10.   DIRECTORS AND EXECUTIVE OFFICERS OF THE COMPANY   93
ITEM 11.   EXECUTIVE COMPENSATION   93
ITEM 12.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS   93
ITEM 13.   CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS   93
ITEM 14.   PRINCIPAL ACCOUNTANT FEES AND SERVICES   93

 
 
PART IV
 
 
         
ITEM 15.   EXHIBITS AND FINANCIAL STATEMENT SCHEDULES   94
SIGNATURES   99

i


PART I

ITEM 1.    BUSINESS

EXCERPTS ON THIS PAGE:

10-K (2 sections)
Mar 31, 2008
10-K
Apr 2, 2007
10-K
Mar 31, 2006
10-K
Mar 30, 2005

RELATED TOPICS for GAIT:

"DOCUMENTS INCORPORATED BY REFERENCE" elsewhere:

Aspect Medical Systems (ASPM)
Advancis Pharmaceutical (AVNC)
Avalon Pharmaceuticals (AVRX)
Immucor (BLUD)
Biopure (BPUR)
BioSphere Medical (BSMD)
Cell Genesys (CEGE)
Cephalon (CEPH)
Clinical Data (CLDA)
Candela (CLZR)
Caraco Pharmaceutical Laboratories (CPD)
CuraGen (CRGN)
Cardiac Science (CSCX)
Cypress Bioscience (CYPB)
Datascope (DSCP)
Diversa (DVSA)
EPIX Pharmaceuticals (EPIX)
EResearch Technology (ERES)
HLTH (HLTH)
Fibrocell Science, Inc. (ILE)
Lipid Sciences (LIPD)
GALECTIN THERAPEUTICS INC (PRW)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki